Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
$7.98
-3.5%
$11.79
$4.88
▼
$15.87
$1.13B2.433.50 million shs2.69 million shs
Cybin Inc. stock logo
HELP
Cybin
$7.20
-6.1%
$11.15
$3.76
▼
$15.15
$574.63M0.641.34 million shs3.02 million shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
-8.21%-9.91%-23.07%-40.50%+59.04%
Cybin Inc. stock logo
HELP
Cybin
-13.53%-18.14%-27.30%-34.28%+766,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
$7.98
-3.5%
$11.79
$4.88
▼
$15.87
$1.13B2.433.50 million shs2.69 million shs
Cybin Inc. stock logo
HELP
Cybin
$7.20
-6.1%
$11.15
$3.76
▼
$15.15
$574.63M0.641.34 million shs3.02 million shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
-8.21%-9.91%-23.07%-40.50%+59.04%
Cybin Inc. stock logo
HELP
Cybin
-13.53%-18.14%-27.30%-34.28%+766,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
2.88
Moderate Buy$23.14190.01% Upside
Cybin Inc. stock logo
HELP
Cybin
3.00
Buy$47.33557.41% Upside

Current Analyst Ratings Breakdown

Latest CMPS and HELP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/9/2026
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
Reiterated RatingBuy
11/9/2026
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
Reiterated RatingBuy
11/4/2026
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
Reiterated RatingOutperform
11/4/2026
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
Lower Price TargetEqual Weight$13.00 ➝ $10.00
11/3/2026
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
Reiterated RatingOutperform$20.00
11/3/2026
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
Reiterated RatingBuy$25.00
10/22/2026
Cybin Inc. stock logo
HELP
Cybin
Boost Price TargetOverweight$16.00 ➝ $22.00
10/15/2026
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
Reiterated RatingSell (D-)
9/18/2026
Cybin Inc. stock logo
HELP
Cybin
Initiated CoverageOverweight$35.00
9/9/2026
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
Reiterated RatingBuy
8/20/2026
Cybin Inc. stock logo
HELP
Cybin
Boost Price TargetBuy$8.00 ➝ $62.00
(Data available from 11/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
N/AN/AN/AN/A$1.00 per shareN/A
Cybin Inc. stock logo
HELP
Cybin
N/AN/AN/AN/A$4.49 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
-$287.86M-$3.49N/AN/AN/AN/A-18.03%-5.11%N/A
Cybin Inc. stock logo
HELP
Cybin
-$148M-$3.02N/AN/AN/AN/A-71.78%-64.81%N/A

Latest CMPS and HELP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/13/2026Q2 2027
Cybin Inc. stock logo
HELP
Cybin
-$0.67-$1.41-$0.74-$1.41N/AN/A
11/3/2026Q3 2026
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
-$0.39-$0.31+$0.08-$0.31N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
N/AN/AN/AN/AN/A
Cybin Inc. stock logo
HELP
Cybin
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
0.35
1.50
1.50
Cybin Inc. stock logo
HELP
Cybin
N/A
10.97
10.97

Institutional Ownership

CompanyInstitutional Ownership
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
46.19%
Cybin Inc. stock logo
HELP
Cybin
17.94%

Insider Ownership

CompanyInsider Ownership
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
2.82%
Cybin Inc. stock logo
HELP
Cybin
15.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
156141.71 million137.71 millionOptionable
Cybin Inc. stock logo
HELP
Cybin
10079.81 million67.84 millionOptionable

Recent News About These Companies

Cybin (NASDAQ:HELP) Stock Falls 7.7% - Time to Sell?
Cybin (NASDAQ:HELP) Sees Large Volume Increase - Here's Why
Traders Buy High Volume of Call Options on Cybin (NASDAQ:HELP)
Cybin (NASDAQ:HELP) Cut to Strong Sell at Wall Street Zen
Cybin Inc. (NASDAQ:HELP) Stock Has Average Price Target of $47.33
Cybin (NASDAQ:HELP) Raised to Sell at Wall Street Zen

New MarketBeat Followers Over Time

Media Sentiment Over Time

Compass Pathways stock logo

Compass Pathways NASDAQ:CMPS

$7.98 -0.29 (-3.51%)
Closing price 04:00 PM Eastern
Extended Trading
$8.12 +0.14 (+1.69%)
As of 07:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Compass Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to Compass Pathways plc in August 2020. Compass Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Cybin stock logo

Cybin NASDAQ:HELP

$7.20 -0.47 (-6.13%)
Closing price 04:00 PM Eastern
Extended Trading
$7.13 -0.07 (-1.03%)
As of 07:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a discovery-phase phenethylamine derivative to treat neuroinflammation and psychiatric conditions. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.